Key result
Small molecule tyrosine kinase inhibitors are associated with cardiovascular side effects including hypertension, heart failure, and QTc prolongation, which may benefit from systems-based approaches.
This review highlights the mechanisms of TKI-induced cardiovascular toxicities and advocates for systems-based approaches to manage cardiovascular wellness in cancer survivors.
Answers are grounded in this paper and cite their sources.
May guide TKI cardiotoxicity monitoring; leaves open prospective validation of systems medicine approaches.
Once universally considered a rapidly fatal condition, cancer has increasingly become a chronic medical condition and comorbidities and adverse effects of cancer therapies have become increasingly significant. One of the leading advancements that has gained traction for the treatment of a variety of malignancies is the class of small molecule tyrosine kinase inhibitors (TKIs). Although, in many aspects revolutionary, TKIs have their own profile of side effects, including cardiovascular side effects, the most common being hypertension (HTN), congestive heart failure, corrected QT (QTc) prolongation, and instances of premature coronary heart disease. Herein, we describe the mechanisms of small TKI-induced cardiovascular toxicity and related intracellular signaling. In particular, systems-based approaches to the understanding of small TKI-induced cardiovascular toxicity are addressed. The pathophysiology of synergic cardiovascular toxicity from TKIs, anthracyclines, and monoclonal antibodies (e.g., trastuzumab, bevacizumab) is illustrated. Finally, recommendations are made for implementing systems medicine in clinical practice, for individualized cardiovascular wellness after cancer therapy.
No takes yet. Share an insight, caveat, or question.
Nhola et al. (2016) conducted a review in Cancer and cardiovascular toxicity. Small molecule tyrosine kinase inhibitors (TKIs) was evaluated. Small molecule tyrosine kinase inhibitors are associated with cardiovascular side effects including hypertension, heart failure, and QTc prolongation, which may benefit from systems-based approaches.
Synapse has enriched 10 related papers. Consider them for comparative context: